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Abstract: Background
Oral antipyretic analgesics are commonly used medicines in children with the potential
for adverse drug reactions (ADRs). The aim of this study was to explore parental
experiences of potential ADRs related to their oral administration of antipyretic
analgesics in children in the Kingdom of Saudi Arabia (KSA).
Methods
For this cross-sectional survey, a paper-based questionnaire, consent form and
information sheet were handed out to 1000 parents who had administered an oral
antipyretic analgesic to their children in the previous three months. Data were entered
and analyzed using SPSS v.21.0 (IBM Corporation, Somers, NY, USA). Simple
descriptive and inferential statistics were used. Management and ethical approvals had
been gained.
Results
In March-April 2017, 661 parents agreed to participate giving a response rate of
66.1%. Of the surveyed sample, 208 parents had observed one or more potential
ADRs (31.5%, n=208/661). Parents (n=208) most commonly reported potential ADRs
(n=523) were: loss of appetite (23%, n=120/523), stomach ache (20.3%, n=106/523),
abdominal colic (13%, n=68/523), and diarrhea (10.3%, n=54/523). Parents described
severity of the ADRs as ‘slight’ (71.8%, n=342/476), ‘annoying to the child…’ (7.9%,
n=85/476), ‘significant and affecting daily tasks’ (3.6%, n=17/476) and ‘significant and
led to the hospital’ (6.7%, n=32/476). Fever was the top ranked reason for using
antipyretic analgesics (41.0%, n=271/661), followed by toothache (25.0%, n=165/661)
and tonsillitis/laryngitis (24.7%, n=163/661). 34.7% of parents (n=165/476) did not seek
medical attention when a potential ADR occurred while 26.3% (n=125/476) of parents
took their children to hospital clinics.
Conclusions
 Although the majority of parentally reported (but not proven) ADRs were mild, a
number of significant ADRs were reported.   Future research should consider whether
there is a role for physicians and pharmacists in  educating parents in KSA, and
perhaps more widely, about the optimal use of oral antipyretics and analgesics in
children.
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Parental experience of potential adverse drug reactions related to their oral 
administration of antipyretic analgesics in children in Saudi Arabia 
 
Abstract 
Background 
Oral antipyretic analgesics are commonly used medicines in children with the 
potential for adverse drug reactions (ADRs). The aim of this study was to explore 
parental experiences of potential ADRs related to their oral administration of 
antipyretic analgesics in children in the Kingdom of Saudi Arabia (KSA). 
Methods 
For this cross-sectional survey, a paper-based questionnaire, consent form and 
information sheet were handed out to 1000 parents who had administered an oral 
antipyretic analgesic to their children in the previous three months. Data were entered 
and analyzed using SPSS v.21.0 (IBM Corporation, Somers, NY, USA). Simple 
descriptive and inferential statistics were used. Management and ethical approvals had 
been gained.  
Results 
In March-April 2017, 661 parents agreed to participate giving a response rate of 
66.1%. Of the surveyed sample, 208 parents had observed one or more potential 
ADRs (31.5%, n=208/661). Parents (n=208) most commonly reported potential ADRs 
(n=523) were: loss of appetite (23%, n=120/523), stomach ache (20.3%, n=106/523), 
abdominal colic (13%, n=68/523), and diarrhea (10.3%, n=54/523). Parents described 
severity of the ADRs as ‘slight’ (71.8%, n=342/476), ‘annoying to the child…’ (7.9%, 
n=85/476), ‘significant and affecting daily tasks’ (3.6%, n=17/476) and ‘significant 
and led to the hospital’ (6.7%, n=32/476). Fever was the top ranked reason for using 
antipyretic analgesics (41.0%, n=271/661), followed by toothache (25.0%, 
n=165/661) and tonsillitis/laryngitis (24.7%, n=163/661). 34.7% of parents 
(n=165/476) did not seek medical attention when a potential ADR occurred while 
26.3% (n=125/476) of parents took their children to hospital clinics.  
Conclusions 
Although the majority of parentally reported (but not proven) ADRs were mild, a 
number of significant ADRs were reported. Future research should consider whether 
there is a role for physicians and pharmacists in educating parents in KSA, and 
perhaps more widely, about the optimal use of oral antipyretics and analgesics in 
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children.  
 
Keywords: antipyretic analgesics, adverse drug reactions, children, parents, survey 
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Introduction 
 
Oral antipyretic analgesics including acetaminophen (paracetamol) and the non-
steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, are commonly used 
medicines in children, with established evidence of efficacy and effectiveness [1-4]. 
Both are classified in many countries, including the Kingdom of Saudi Arabia (KSA), 
as ‘over-the-counter’ (OTC) medicines with ease of availability and access to parents 
for oral administration to their children. Antipyretic analgesics are reported as being 
the most common OTC medicines purchased by the public in KSA and freely 
available on prescription from governmental hospitals or for a charge from private 
pharmacies. [5]. However, this ease of availability has led to cases of incorrect dose 
administration by parents with their children, resulting in potential adverse drug 
reactions (ADRs) [6]. ADR is defined by the Medicines and Healthcare products 
Regulatory Agency (MHRA) as ‘an unwanted or harmful reaction which occurs after 
administration of a drug or drugs’ [7]. 
  
Children are prone to issues of drug misuse and overdose of medicines [8, 9]. 
Described by Torissi et al. (2018) as a challenging to research population given that 
children are ‘very sensitive to the undesirable effects of the drugs due to their 
physiological differences’ [10]. ADRs account for between 4 and 6% of hospital 
admissions, with incorrect drug dosage constituting one of the leading causes for 
ADRs [7, 8]. Several studies reported ADRs in children when administered higher 
than recommended doses [1-6, 8-14]. These reactions included gastrointestinal, renal, 
and hepatic system ADRs. Several factors affect the exposure of children to 
antipyretic analgesics rendering children more vulnerable to potential ADRs [8-10]. A 
major determinant was parental misconceptions about the potentially harmful effects 
of fever on their children. Hence the perceived need to act quickly in reducing a raised 
temperature by administering oral antipyretic analgesics [6]. Furthermore, as children 
are a diverse group in terms of weight and age they experience variable responses to 
drugs resulting in potential ADRs [8-10]. Li et al. (2011) reported that the highest 
percentage of drug overdose cases seen in hospital emergency departments were in 
children under the age of five years old [15].  
 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
         
4 
Several factors contributed to the overdose and misuse of medicines which included 
parents’ lack of knowledge and inexperience in how to correctly administer oral 
antipyretic analgesics [6, 15]. Miscalculation of the doses based on weight, 
individualized dosing and medication liquid formulation, can lead to greater risk of 
dosing errors in children [16, 17]. A study conducted to assess parental ability to 
correctly calculate the appropriate acetaminophen dose found that only 30 out of 100 
parents were able to do so [18]. Inappropriate storage and disposal of medicines is 
another cause of misuse [19].  A large study comprising 1,641 households from 22 
cities reported that 80% of Saudi homes had an average of at least two expired or 
unused medicines, with oral antipyretic analgesics constituting half of these medicines 
[20]. Recently, the Saudi Food and Drug Authority warned against overdosing 
children less than 12 years of age with paracetamol and there are ongoing concerns 
about the misuse of analgesics and other medicines by the public in KSA [21].  
 
The aim of this study was to explore parental experiences of potential adverse drug 
reactions related to their oral administration of antipyretic analgesics in children in 
Saudi Arabia. 
 
Methods 
 
Research Design  
A cross-sectional survey using a paper-based questionnaire was handed out with an 
information sheet and consent form to the parents of children who had used an oral 
antipyretic analgesic, with or without a prescription, in the previous three months.  
 
Setting and Recruitment Process  
This study was conducted in March - April 2017 in pediatric outpatient clinics, 
pediatric emergency rooms and hospital waiting areas at four hospitals in Jeddah, 
KSA: the Maternity and Children’s Hospital, the East Jeddah General Hospital, the 
King Abdul-Aziz Hospital and the Maternity and Children’s Hospital Al-Aziziah. 
Parents were recruited by convenience sampling without any stratification. The 
researcher handing out the study materials offered assistance to any parents who 
needed help with completing the questionnaire. 
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Questionnaire 
The questionnaire was based on a recent study of ADRs conducted by members of the 
research team [21, 22]. It included the following items: demographics (which parent 
filled in the questionnaire, age of child, gender, number of siblings, parents’ levels of 
education), symptoms and frequency of any previously experienced ADRs, severity of 
each ADR, and if the child had previously suffered ADRs which parents believed 
were attributable to the use of antipyretic analgesics. The severity of the potential 
ADR was categorized by parent respondents as ‘slight’, or ‘annoying to the child or 
an allergy but they were still able to perform their daily tasks’, or ‘significant and 
affecting daily tasks’, or ‘significant and led to the hospital’, or lastly, ‘fatal’. Other 
items collected in the questionnaire focused on parents’ reasons for administering oral 
antipyretic analgesics, where parents would obtain these medicines, who parents 
would consult on use of these medicines, whether parents read the medicines 
information leaflet, under which circumstances parents would re-use remaining 
prescribed oral antipyretic analgesic medicines, and parents’ experience of providing 
the right dose of antipyretic analgesics. 
 
The questionnaire was tested for face and content validity by a panel of 10 academic 
and healthcare staff and then piloted with 12 parents. No changes were made to the 
questionnaire post-pilot, so these responses were included in the final dataset. 
Completed questionnaires were collected by clinical staff and stored securely for 
research team collection.  
 
Data Analysis  
Questionnaire data were entered and analyzed using SPSS v.21.0 (IBM Corporation, 
Somers, NY, USA). Simple descriptive and inferential statistics were used in 
reporting the results.  
Ethical approval 
Management authorization had been gained from the Ministry of Health (M.O.H) 
Reference Number (892225) and ethical approval from the National Committee of 
Bio and Medical Ethics, Reference Number (872863). 
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Results 
 
One-thousand information sheets, consent forms and questionnaires were handed out 
with 661 parents agreeing to participate in the survey, giving a response rate of 
66.1%. Mothers accounted for 63.8% (n=422/661), and 27.8% (n=184/661) were 
fathers with the remainder (8.3%, n=55/661) not disclosed. Demographics and 
experience of administering antipyretic analgesics are reported in Table 1 with details 
of potential ADRs in Table 2. Parents’ responses related more to sons (44.8%, 
n=296/661) than daughters (38.1%, n=252/661) with the remainder again not 
disclosed (17.1%, n=113/661). The children were aged below five years of age (29%, 
n=192/661), with 58.9% in the 5 years to under 10 years age group (n=389/661) while 
12.1% of the children were 10 years or older (n=80/661). Most were from families of 
2 to 5 children (57.5%, n=380/661). The majority of mothers (52.6%, n=348/661) and 
fathers 58.4% (n=386/661) had completed higher education. However, some mothers 
(15.1%, n=100/661) and fathers (3.8%, n=25/661) described themselves as ‘illiterate’. 
Assistance was offered in completing the questionnaire. 
 
Frequency of potential ADRs, severity and causality: Of the surveyed sample, 208 
parents had observed one or more potential ADRs (31.5%, n=208/661). The most 
commonly reported potential ADRs (n=523) were: loss of appetite (23%, n=120/523), 
stomach ache (20.3%, n=106/523), abdominal colic (13%, n=68/523), diarrhea 
(10.3%, n=54/523), bloody stool (7.6%, n=40/523) and anxiety (5.4%, n=28/523). 
Less frequent potential ADRs were rash (5.4%, n=28/523) and weight loss (5.2%, 
n=27/523), feeling of isolation (5.0%, n=26/523, anemia (3.6%, n=19/523) and 
fatigue (1.3%, n=7/523).  Regarding the severity of the potential ADRs, 71.8% 
(n=342/476) were perceived by parents as 'slight', 17.9% (n=85/476) perceived the 
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ADRs  as ‘annoying to the child or an allergy but they were still able to perform their 
daily tasks’ or 'significant and affecting daily life tasks' (3.6%, n=17/476) when 
describing the potential ADR and 6.7% (n=32/476) perceived them as ‘significant and 
led to the hospital’; none reported experiencing a fatal potential ADR. Respondents 
were either certain that the antipyretic analgesic had caused the adverse reaction 
(33.9%, n=224/661) or disagreed (28%, n=185/661) or were uncertain (38.1%, 
n=252/661). Only 40.4% of parents (n=84/208) were able to name the medication 
they believed had caused the potential ADR with acetaminophen (paracetamol) and or 
ibuprofen, carrying different brand names and concentrations. 
 
Reasons to use antipyretic analgesics: Fever was the top ranked reason for using 
antipyretic analgesics (41.0%, n=271/661), followed by toothache (25.0%, 
n=165/661) and tonsillitis/laryngitis (24.7%, n=163/661). 
 
Parents' knowledge of the correct dose of antipyretic analgesics: 71% (n=467/661) 
of all the respondents believed they were experienced in giving the right dose of 
medicines. However, 19.3% (n=128/661) stated they were not and 10.0% (n=66/661) 
indicated ‘maybe’.  
 
Consultation on use and purchasing of antipyretic analgesics: 64.7% of parents 
(n=427/661) consulted a doctor prior to using oral antipyretic analgesics, 19.8% 
consulted a pharmacist (n=131/661) while 12.6% consulted family members 
(n=83/661) and very few asked friends (1.8%, n=12/661) or searched on the Internet 
(1.2%, n=8/661). Most parents (80.2%, n=530/661) read the enclosed medication 
leaflet, however, 19.8% did not (n=131/661). Parents most commonly obtained oral 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
         
8 
antipyretic analgesics through a physician’s prescription (72.3%, n=478/661) and 
26.5% purchased these medicines without a prescription (n=175/661). Very few 
bought directly from supermarkets (1.1%, n=7/661) or online (0.2%, n=1/661).  
 
Re-use of previously prescribed antipyretic analgesics for their child for another 
illness without medical consultation: 57.7% of parents (n=381/661) stated that they 
would re-use an oral antipyretic analgesic previously prescribed for their child for 
another illness without medical consultation. The remainder would not re-use the 
medication (31.6%, n=209/661) or did not respond to this question (10.7%, 
n=71/661). 
 
Parents' response following a potential ADR affecting their children: 34.7% of 
parents (n=165/476) stated that they did not seek medical attention when a potential 
ADR occurred while 26.3% of parents (n=125/476) took their children to hospital. 
The remainder either stopped giving the medicine (16.6%, n=79/476) or would take 
their child to the hospital emergency room (7.4%, n=35/476). When parents were 
asked whether they thought that the medication they gave to their children caused the 
potential ADR, responses were ‘yes’ (33.9%, n=224/661), ‘no’ (28%, n=185/661) and 
‘uncertain’ (38.1%, n=252/661).  
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Discussion 
This research study investigated parental experience of potential adverse drug 
reactions related to their oral administration of antipyretic analgesics in children in 
Saudi Arabia. The results show that some parents experienced their child suffering 
one or more potential ADRs, a small proportion of which were sufficiently severe the 
concerned parents took their child to hospital. Given that one in five parents admitted 
not reading the enclosed information leaflet, it can be concluded that they were either 
unsure or did not have the experience to provide the correct dose of oral antipyretic 
analgesic. Together with more than half of the parents re-using medications 
prescribed for a possibly different condition, it is incumbent on pharmacists to 
counsel thoroughly using short, clear, non-technical messages.  
  
Parents reported common and less common ADRs associated with their child's 
antipyretic analgesic medicines use. Most were mild and commonly recognized in 
clinical trials and post-marketing surveillance studies [3, 4].  The most common 
potential ADRs reported by parents in this study were loss of appetite, stomach ache 
and abdominal colic. Less frequent potential ADRs were rash, weight loss and 
anemia. Even though rashes were reported in this study, nonetheless they are 
considered in the literature as rare potential ADRs in response to NSAIDs [23]. Of 
great concern were the two-hundred sixty-eight (n=51.2%) cases of gastrointestinal 
tract (GIT) ADRs with complications including rectal bleeding and anemia reported 
in this study (Table 2). GIT adverse effects, including peptic ulcer, bleeding and 
perforation are known to be associated with the use of NSAIDs occurring due to 
mucosal prostaglandin depletion and are considered as rare ADRs [24]. A population-
based survey conducted in France to describe upper gastrointestinal bleeding (UGIB) 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
         
10 
reported in 177 children, aged between 2 months and 16 years, revealed that 83 
children were prescribed at least one NSAID in the seven days preceding the 
admission and one-third of the UGIB were deemed attributable to use of ibuprofen or 
aspirin at analgesic or antipyretic dose [25]. 
 
Other determinants such as parental level of education clearly had an effect on the 
administration of oral antipyretic analgesics. Surprisingly in this study, parents with a 
high level of education, such as college or university degree, still did not read the 
medication leaflet and often consulted family members rather than medical 
professionals prior to administering the antipyretic analgesics. It would be expected 
that level of literacy would play an important role in understanding drug related 
instructions. However, parents could still be confused and miscalculate doses [26-28]. 
We suggest providing education and clear instructions to parents, as well as 
healthcare professionals, on the appropriate use of oral antipyretic analgesics in 
children. Fever is one of the most commonly consulted pediatric symptoms but there 
is a lack of consensus in the guidance available to parents on the optimal way to 
manage it [29-33]. Thus, appropriate counseling of the parents on fever, and the 
proper use of oral antipyretic analgesics to manage it, should be encouraged.  
 
The majority of parents (58%) re-used medications previously prescribed for their 
child for another illness without medical consultation. This has been shown to be a 
major contributing factor for ADRs [34, 35]. Although we cannot be certain of any 
link between reported ADRs and the medicines under investigation, it is clear that the 
children’s parents have made such a link to oral antipyretic analgesics. Educating the 
public on the importance of correctly disposing of unused medicines, as well as 
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consulting physicians prior to the re-use of any medicines, is crucial [31]. Schemes to 
dispose of unused medication have been successfully carried out in some countries 
[34, 35]. Previous studies found similar results about parental lack of knowledge 
regarding ADRs associated with medicines [36-38].  
 
It is important for a physician to describe in appropriately measured language the 
correct use of antipyretic analgesics to parents whether or not they have previously 
been counselled on using similar medication. Additionally, there is a major role to be 
played by pharmacists, as they can provide appropriate advice on the management of 
fever and pain. Although ibuprofen and acetaminophen are generally regarded as well 
tolerated and effective when used appropriately for the management of fever and pain 
in children, they should be used cautiously in order to minimize the risk of ADRs [34-
38].  
 
A limitation of this study is the possibility of recall bias in parents’ experience of oral 
antipyretic analgesics with their children which could affect the results. Also, it 
should be noted that some questionnaires were filled in by parents in outpatient clinics 
attending because of concerns about their child’s health which could again have 
influenced their answers. With some parents identifying as ‘illiterate’ the 
administration of the survey by a researcher rather than self-completion may have 
introduced some inconsistency. A further limitation was not asking specifically 
whether the child was admitted to hospital as a consequence of any potential ADRs. 
 
Conclusions 
Not unexpectedly, parental experiences of potential ADRs related to their oral 
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administration of antipyretic analgesics to their children in Saudi Arabia were varied. 
Although the majority of parentally reported (but not proven) ADRs were mild, a 
significant number of severe ADRs were reported. Future research should consider 
whether there is a role for physicians and pharmacists in educating parents in KSA, 
and perhaps more widely, about the optimal use of oral antipyretics and analgesics in 
children.  
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Table 1. Demographics of participants and experience of administering oral antipyretic analgesic 
in children 
 
Demographics 
n=661 
Number of parents 
 n (%) 
Mothers education 
Illiterate  100 (15.1%) 
Primary 4 (0.6%) 
Intermediate 8 (1.2%) 
Secondary 193 (29.2%) 
University 348 (52.6%) 
Higher Studies 8 (1.2%) 
Fathers education 
Illiterate 25 (3.8%) 
Primary 10 (1.5%) 
Intermediate 19 (2.9%) 
Secondary 212 (32.1%) 
University 386 (58.4%) 
Higher Studies 9 (1.4%) 
Age of child attending paediatric outpatient clinic 
< 5 years 192 (29.0%) 
5 and < 10 years 38 (58.9%) 
>= 10 years 80 12.1%) 
Do you have experience of providing the correct dose of 
antipyretic analgesic? 
Yes 467 (70.7%) 
No 128 (19.3%) 
Maybe 66 (10.0%) 
Who did you consult before using the antipyretic analgesic? 
Family 83 (12.6%) 
Physician 427 (64.6%) 
Pharmacist 131 (19.8%) 
Friend 12 (1.8%) 
Internet 8 (1.2%) 
Did you read the enclosed leaflet attached to the antipyretic 
analgesic? 
Yes 530 (80.2%) 
No 131 (19.8%) 
How did you obtain the antipyretic analgesic? 
Physician’s prescription 478 (72.3%) 
Without prescription 175 (26.5%) 
The supermarket 7 (1.1%) 
From the internet 1 (0.2%) 
Would you reuse an antipyretic analgesic previously 
prescribed to your child for another illness without medical 
consultation? 
Yes 381 (57.7%) 
No 209 (31.6%) 
Maybe 71 (10.7%) 
Reasons for using antipyretic analgesic for your child? 
Fever 271 (41.0%) 
Table          
2 
Toothache 165 (25.0%) 
Tonsillitis and laryngitis 163 (24.7%) 
Earache 46 (7.0%) 
After traumas, burns or rashes 6 (0.9%) 
After trauma or bruises 3 (0.5%) 
Other 7 (1.1%) 
 
 
         
Table 2. Parents’ experience of ADR following administration of oral antipyretic analgesic in 
children 
 
  
ADRs observed by parents in their children (n=523)* 
Appetite loss  120 (22.9%) 
Stomach ache 106 (20.3%) 
Abdominal Colic    68 (13.0%) 
Diarrhea 54 (10.3%) 
Blood in stool  40 (7.6%) 
Anxiety 28 (5.4%) 
Rash 28 (5.4%) 
Weight loss 27 (5.2%) 
Isolation  26 (5.0%) 
Anemia 19 (3.6%) 
Fatigue 7 (1.3%) 
Severity of the ADRs affecting the children (n=476)* 
Slight 342 (71.8%) 
Annoying to the child or an 
allergy but they were still able 
to perform their daily tasks 
85 (17.9%) 
Significant and affecting daily 
life tasks 
17 (3.6%) 
Significant and led to the 
hospital 
32 (6.7%) 
Fatal 0 (0.0%) 
Do you think that the antipyretic analgesic used caused 
these adverse effects? (n=661)* 
Yes 224 (33.9%) 
No 185 (28.0%) 
Uncertain 252 (38.1%) 
What was your decision when an ADR occurred with your 
child? (n=476)* 
I didn't do anything 165 (34.7%) 
I went to the hospital clinic 125 (26.3%) 
I went to the ER 35 (7.4%) 
I stopped the medication 79 (16.6%) 
I consulted a pharmacist 11 (2.3%) 
I consulted a physician 48 (10.1%) 
The physician changed the 
medication 
2 (0.4%) 
The physician lowered the dose 8 (1.7%) 
Other 3 (0.6%) 
*not all parents observed an ADR;  
some parents observed multiple ADRs 
Table          
